Jellagen Boosts Scientific Advisory Board with New Appointments Dr Mike Barbeck and Dr Andy Weymann
Jellagen announces the appointments of Dr Mike Barbeck and Dr Andy Weymann to the Scientific Advisory Board
READ POSTBlog
Jellagen on the BBC World Service
Jellagen were visited by the BBC who wanted to talk to us about our jellyfish collagen and the opportunities it creates
READ POSTJellagen® extends coverage in Asia Pacific with new distributor agreements
The companies will act as exclusive distributors of Jellagen’s products and services across their respective regions of India and South Korea.
READ POSTJellagen® announces collaboration with Mayo Clinic
jellagen has entered into a license agreement for an exclusive grant to patent rights with Mayo Clinic for the development in treatment of vocal cord paralysis.
READ POSTNew Research Paper: Biological Evaluation of Jellyfish Collagen as a New Research Tool for the Growth and Culture of iPSC Derived Microglia
Microglia Cells on Jellagen® demonstrated a more ramified “microglial-like” cell morphology compared to cells cultured on mammalian Rat Tail Collagen I and Laminin-511
READ POSTNew Research Paper: In Vivo Analysis of the Biocompatibility and Immune Response of Jellagen 3D Scaffolds
In Vivo Analysis of the Biocompatibility and Immune Response of Jellyfish Collagen Scaffolds and its Suitability for Bone Regeneration
READ POSTJellagen® announces £1.9m seed financing to develop products for therapeutic and medical device applications
The £1.9m round, which was 75% funded by international investors, will enable Jellagen to develop and partner pipeline products aimed at tissue reconstruction, diabetic wound care management and rare skin diseases.
READ POSTNeurons & Astrocytes on Jellagen®
Jellagen was shown to have an increased level of synchronisation when compared against Matrigel
READ POSTVideo Interview with Mike Barbeck
Discover why collagen is such an important component for successful cell culture
READ POSTJellagen® announces new Chairman of the Board, Gregg Sando.
Gregg replaces Stephane Thiroloix who will remain as a non-executive director at Jellagen®.
READ POST
